Analystreport

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its price target raised by analysts at HC Wainwright from $30.00 to $35.00. They now have a "buy" rating on the stoc

Aurinia Pharmaceuticals Inc - Common Shares  (AUPH) 
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.auriniapharma.com